This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

ANI Pharmaceuticals Inc (ANIP)

NASDAQ: Health Care

Company Profile
Price and Volume
Recent Price 50.87
52 Week High 72.61
52 Week Low 24.24
Avg. Daily Vol. (Mil) 0.31
Beta (3 year) 3.68
Share Related Items
Mkt Cap (Mil) 580.66
Shares Out (Mil) 11.43
Float (Mil) 7.84
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 20.20
Current Ratio 22.40
LT Debt/ Equity 0.77
Total Debt / Equity 0.77
Valuation Ratios
Price Earnings 19.20
Price/Sales 9.10
Price/Book 4.02
Price/Cash Flow 17.00
Per Share Data
Earnings 2.65
Sales 5.59
Book Value 12.67
Cash Flow 3.00
Business Summary
ANI Pharmaceuticals Inc is a specialty pharmaceutical company. The Company, together with its subsidiary develops, manufactures and markets branded and generic prescription pharmaceuticals products.
General Information
210 Main Street West
Baudette, MN 56623
www.anipharmaceuticals.com
Industry : Drugs
Sector: Health Care
Employees: 92
CEO: Arthur S. Przybyl
Short Interest
Current Month (Mil) 1.50
Previous Month (Mil) 1.33
Short Interest Ratio (Days) 5.40
Management Effectiveness
Return on Equity 20.60
Return on Assets 11.20
Return on Investments 11.60
Profitability
Gross Margin 81.80
EBIT Margin 41.10
Profit Margin 46.60
ANIP News

ANIP ANI Pharmaceuticals Inc

Analysts Ratings for ANIP

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 2 2
Moderate Buy 0 0 0 0
Hold 1 1 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ANIP ANALYST REPORT

Brokerage Partners

ANIP Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs